Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Carcinoma, Hepatocellular 9Neoplasms 8Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Nasopharyngeal Carcinoma 6Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Esophageal Neoplasms 5Recurrence 4Esophageal Squamous Cell Carcinoma 4Colonic Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Lung Neoplasms 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Solid Cancers 2Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Ovarian Neoplasms 2Gastric / Gastroesophageal Junction Adenocarcinoma 2EBV-associated Tumors 2Cholangiocarcinoma 2Breast Neoplasms 2Bites and Stings 2Biliary Tract Neoplasms 2Advanced Solid Tumors 2

Interventions

Cisplatin 32Radiotherapy, Intensity-Modulated 21Magnetic Resonance Spectroscopy 21Radiotherapy 16Specimen Handling 15Radiation 14Carboplatin 14pembrolizumab 13Platinum 121,2-diaminocyclohexaneplatinum II citrate 11Paclitaxel 8Chemoradiotherapy 7Biopsy 7Taxes 6Surveys and Questionnaires 6Cetuximab 6Nivolumab 5Surgical Procedures, Operative 4Observation 4Fluorodeoxyglucose F18 4Drug Therapy 4Docetaxel 4durvalumab 3(225)Ac-DOTA-c(RGDyK) 3toripalimab 2cemiplimab 2atezolizumab 2aldesleukin 2X-Rays 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Immune Checkpoint Inhibitors × 1 year × Clear all
NCT07457099 2026-03-09

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Zhujiang Hospital

Not yet recruiting
85 enrolled
Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡